Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: A Study of Strategies to Improve Schizophrenia Treatment [NA]
A completed clinical trial evaluating strategies to improve treatment for schizophrenia and schizoaffective disorder has finished.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Functional Rehabilitation of Older Patients With Schizophrenia [NA]
A completed clinical trial evaluated functional rehabilitation for older patients with schizophrenia and related psychotic disorders; result…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Definitive Estrogen Patch Study (ADEPT) [Phase 2]
A phase 2 clinical trial (ADEPT) evaluating an estrogen patch for schizophrenia and related disorders has completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: L-arginine add-on Therapy in Patients With Schizophrenia [NA]
A clinical trial evaluating L-arginine as add-on therapy for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Bioavailability of LY03004 and Risperdal® Consta® [Phase 1]
Phase 1 study evaluating the bioavailability of LY03004 relative to Risperdal Consta (paliperidone palmitate) has been completed. The trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders [EARLY_Phase 1]
An early Phase 1 trial evaluating a dopamine D1 receptor agonist for cognitive enhancement in schizophrenia and schizoaffective disorder has…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: The Effects of Rimonabant, on Weight and Metabolic Risk Factors [Phase 2]
Phase 2 trial investigating the effects of rimonabant on weight and metabolic risk factors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]
A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 clinical trial update for RP5063 in schizophrenia and schizoaffective disorder. The study completed and results were posted in Janua…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [Phase 2]
A Phase 2 clinical trial update reporting completion of a study evaluating how treatment interruption affects re-initiation of bifeprunox in…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia [Phase 2]
Phase 2 study evaluating twice-daily titration of bifeprunox in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder [Phase 2]
Phase 2 trial update examining progressively decreasing titration schedules of bifeprunox in individuals with schizophrenia or bipolar disor…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness [NA]
Clinical trial update on the In SHAPE fitness intervention for adults with serious mental illness indicates the study status is COMPLETED. T…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI [NA]
This ClinicalTrials.gov update reports that the statewide program to prevent early mortality and promote fitness in persons with serious men…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating paliperidone palmitate for relapse prevention in schizoaffective disorder has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: An Open Trial of Cysteamine Treatment in Schizophrenia [NA]
An open-label clinical trial of cysteamine for schizophrenia (also studied for schizoaffective disorder) was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia [Phase 2]
A Phase 2 proof-of-concept trial evaluated adding pipamperone to stable risperidone or paliperidone therapy in chronic schizophrenia (also r…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Effectiveness of Ziprasidone for Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating the effectiveness of ziprasidone for patients with schizophrenia, with schizoaffective disorder als…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Effects of Metformin and Fish Oil on Treatment With Clozapine [Phase 4]
Phase 4 clinical trial on the effects of adding metformin and fish oil to clozapine in schizophrenia/schizoaffective disorder; study termina…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]
Phase 1 pharmacokinetic and safety study of LY03004 in stable schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. [NA]
A completed clinical trial evaluated FMPO for improving quality of care in people with severe mental illness; results were posted in 2014 fo…
-
FDA label_change · 2014-09-30FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental labeling application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Risperdal Consta and Health Care Utilization in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating health care utilization in patients with schizophrenia treated with Risperdal Consta (risperidone long-act…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence [Phase 4]
Phase 4 clinical trial evaluating the effects of Risperdal Consta in patients with schizophrenia or schizoaffective disorder who have incomp…